Related Experiment Video
Updated: Sep 4, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
The role of cytokines in MET-enkephalin-modulated nitric oxide release
T Marotti1, T Balog, R Mazuran
1Department of Biology and Medicine, Ruder Bosković Institute, Zagreb, Croatia.
Abstract:
In the present study the in vitro and in vivo effect of Met-enkephalin (MENK) on nitric oxide (NO) release by mouse peritoneal macrophages was evaluated. While in vitro MENK was ineffective unless combined with suboptimal concentrations of recombinant murine interferon gamma, in vivo all the doses (2.5, 5 or 10 mg/kg bw) bimodaly modulated NO release. Only the stimulative (2.5 and 10 mg/kg bw) and not the suppressive (5 mg/kg bw) dose of MENK was opioid receptor-mediated as demonstrated by abolishing the effect by naloxone. The stimulative effect of the low (2.5 mg/kg bw) dose, that was observed only if MENK was injected p.m., was associated with the IL production and IFN gamma as demonstrated by abolishing the effect by specific antibodies. The data additionally support the idea that opioid-mediated responses might be to a large degree mediated by the release of cytokines.
Insights
Met-enkephalin (MENK) affects nitric oxide (NO) release from macrophages differently in vitro and in vivo. In vivo, MENK bimodally modulated NO release, with stimulatory effects mediated by opioid receptors and cytokines.
Area of Science:
- Immunology
- Neuroscience
- Pharmacology
Background:
- Nitric oxide (NO) plays a crucial role in immune responses.
- Opioid peptides, like Met-enkephalin (MENK), can modulate immune cell function.
- The interaction between opioid signaling and NO production in macrophages is not fully understood.
Purpose of the Study:
- To investigate the in vitro and in vivo effects of Met-enkephalin (MENK) on nitric oxide (NO) release by mouse peritoneal macrophages.
- To determine the involvement of opioid receptors and cytokines in MENK-induced NO modulation.
Main Methods:
- In vitro and in vivo experiments using mouse peritoneal macrophages.
- Administration of varying doses of MENK (2.5, 5, 10 mg/kg bw).
- Assessment of NO release, with and without naloxone (opioid receptor antagonist) and specific cytokine antibodies (anti-IL, anti-IFN gamma).
Main Results:
- In vitro, MENK alone did not affect NO release, but enhanced it when combined with suboptimal interferon gamma (IFN gamma).
- In vivo, MENK exhibited bimodal modulation of NO release: stimulatory at 2.5 and 10 mg/kg, and suppressive at 5 mg/kg.
- The stimulatory effects were opioid receptor-mediated (blocked by naloxone) and associated with interleukin (IL) and IFN gamma production (blocked by specific antibodies).
- The suppressive dose did not involve opioid receptors.
Conclusions:
- Met-enkephalin modulates nitric oxide release from macrophages in a dose-dependent and context-specific manner.
- In vivo, MENK's stimulatory effect on NO release is mediated through opioid receptors and involves the induction of cytokines like IL and IFN gamma.
- These findings suggest that opioid-mediated immune responses can be significantly influenced by cytokine release.
Related Concept Videos
Paracrine Signaling
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway
Nitric Oxide Signaling Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Acute Inflammation III: Local and Systemic Effects

